Status:

UNKNOWN

Epidemiology and Prognosis of ARDS After Pulmonary Resection Surgery

Lead Sponsor:

University Hospital, Montpellier

Conditions:

Thoracic

Pulmonary Restrictive Disease

Eligibility:

All Genders

18+ years

Brief Summary

The improvement in ARDS mortality over the last 20 years seems to be largely explained by the reduction of mechanical ventilation-induced injury (VILI). VILI is essentially related to volotrauma close...

Eligibility Criteria

Inclusion

  • Inclusion criteria:
  • \- Patient hospitalized following ARDS after thoracic resection surgery
  • Exclusion criteria:
  • \- Refusal to participate after receiving the information letter

Exclusion

    Key Trial Info

    Start Date :

    January 1 2012

    Trial Type :

    OBSERVATIONAL

    Allocation :

    ESTIMATED

    End Date :

    December 1 2021

    Estimated Enrollment :

    50 Patients enrolled

    Trial Details

    Trial ID

    NCT04818554

    Start Date

    January 1 2012

    End Date

    December 1 2021

    Last Update

    March 30 2021

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    UH Montpellier

    Montpellier, France, 34295